Over the past 32 years ChemDiv has successfully completed hundreds of leads, candidates and new drug programs to treat cancer, neurological, infectious, cardiometabolic and immune diseases with pharma, biotech and academic partners around the globe. We are revolutionizing the field of drug discovery by harnessing the power of Hybrid Artificial Intelligence (AI) /Machine Learning (ML) which is curated by our scientists at each step in the process.
Search in
Structure Search
List Search
Browse and Order Libraries
Complete List of Compound Libraries
Focused and targeted libraries
- 100 predesigned libraries
- 19 therapeutical areas
- Dispatched in any custom format
Active Reference Sets
- 17 annotated libraries
- >180K active compounds
- >25K targets
- >190K activity data
Diversity Libraries
- Perfect diversity scoring by Tanimoto
- Focus on novel chemistry by Markush fragments
- High MCE-18 score
- Available as pre-plated sets and as custom-made selections
Preplated libraries
- Represents 30B virtual space of drug-like and lead-like compounds
- Сompounds passed REOS and PAINS, have optimized solubility and «target diversity» approach
- Compounds from over 70 targeted and focused libraries
- Cherry-pick by plates
- 96 or 384 plates format
See also:
30+
years of industrial experience
47
approved drugs
2700+
satisfied customers
5
R&D hubs worldwide
Popular
CELMoDs library
Covalent Inhibitors Library
Covalent lysine binder library
Covalent serine binders library
3D-Pharmacophore Based Diversity Library
52,000 compounds
Representative Diversity Libraries
50,000 / 100,000 / 150,000 compounds
Fast follow-up SAR diverse screening library
155,000 compounds
Cardiovascular Library
23,000 compounds
Aryl hydrocarbon receptor (AHR) modulators library
16,846 compounds
tTG2 library
23,000 compounds
IMiD small molecule library
2000 compounds
Antiviral Library
87,000 compounds
Team ChemDiv, Inc. at AACR 2024, San Diego!
Last week, our team had the incredible opportunity to attend the Annual Meeting of the American Association for Cancer Research (AACR) in San Diego.
Novel Potent TIM-3 Inhibitors were discovered in ChemDiv’s collection.
The ChemDiv’s proprietary library of chemically diverse small molecule compounds was demonstrated to be a source of selective inhibitors targeting specific check points was found out in a recen...
ChemDiv Company in publications and patents
We are passionate about the latest trends in life sciences and medicinal chemistry and closely monitoring the latest developments and discoveries in this area.
It means a lot to us if our custome...
Glenmark announces recall of high blood pressure medication in US
Glenmark Pharmaceuticals’ US-based unit has announced the recall of 6,528 bottles of Diltiazem Hydrochloride extended-release capsules for treating high blood pressure.
Event Calendar
April 5-10 2024. AACR ANNUAL MEETING 2024.
April 10-11 2024. ChemBio Finland.
April 15-17 2024. GMMCDD2024 2nd Global Meet on Medicinal Chemistry, Drug Discovery & Drug Delivery
April 29-30 2024. Stanford Drug Discovery Conference.
May 02-03 2024. Drug Discovery and Medicinal Chemistry Innovation
May 03-07 2024. American Association of Immunologists107th annual meeting
May 07-08 2024. Digital Pathology & Al Congress USA
May 14-15 2024. Pharma Partnering Summit US
May 15 2024. Medicinal Chemistry Strategy Meeting East Coast 2024
May 22 2024. Medicinal Chemistry Strategy Meeting West Coast USA 2024
June 03-06 2024. BIO 2024
June 06-08 2024. MEDCHEMMEET2024-3RD INTERNATIONAL MEET ON MEDICINAL CHEMISTRY, DRUG DISCOVERY & DRUG DELIVERY